A practical reference on purity testing: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-18. Anything still debated is marked as such rather than presented as settled.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Latinopoulou has long accused New Democracy under Mitsotakis of being a center-left party masquerading as a center-right party and Mitsotakis as an "unrepentant socialist" and secret leftist, and that after over half a decade in government that the current state of homelessness, unsafe trains, and drug dealing and criminality in the public universities is something that after so many years in power New Democracy must support, since, according to Latinopoulou "What they tolerate they want") While refusing to vote for an EU inquiry into the Tempi case due to what she has argued would create a dangerous EU legal authority precedence in Greece, she has nonetheless called what she views as the Mitsotakis' government having done "nothing" to make the trains safer since the incident as a sign of their "heartlessness" and supports Greek legal inquiries but not EU legal inquiries into the matter. She has publicly stated as well that on the character of Kyriakos Velopoulos and as well on the case of Tempi that he is a "know-it-all geezer" who is a "fraud and a scammer" and that she is the only serious right-wing alternative to the "center left New Democracy party."
==== Black or red ==== Feces can be black due to the presence of red blood cells that have been in the intestines long enough to be broken down by digestive enzymes. This is known as melena, and is typically due to bleeding in the upper digestive tract, such as from a bleeding peptic ulcer. Conditions that can also cause blood in the stool include hemorrhoids, anal fissures, diverticulitis, colon cancer, and ulcerative colitis. The same color change can be observed after consuming foods that contain a substantial proportion of animal blood, such as black pudding or tiết canh. Black feces can also be caused by a number of medications, such as bismuth subsalicylate, activated charcoal, and dietary iron supplements, or foods such as beetroot, black liquorice, or blueberries. Hematochezia is similarly the passage of feces that is bright red due to the presence of undigested blood, either from lower in the digestive tract, or from a more active source in the upper digestive tract. Alcoholism can also provoke abnormalities in the path of blood throughout the body, including the passing of red-black stool. Hemorrhoids can also cause surface staining of red on stools, because as they leave the body the process can compress and burst hemorrhoids near the anus.
RSH + R'CO2H → RSC(O)R' + H2O A typical dehydration agent is DCC. Efforts to improve the sustainability of thioester synthesis have also been reported utilising safer coupling reagent T3P and greener solvent cyclopentanone. Acid anhydrides and some lactones also give thioesters upon treatment with thiols in the presence of a base. Thioesters can be conveniently prepared from alcohols by the Mitsunobu reaction, using thioacetic acid. They also arise via carbonylation of alkynes and alkenes in the presence of thiols.
== Medical uses == Baclofen is primarily used for the treatment of spastic movement disorders, especially in instances of spinal cord injury, and multiple sclerosis. Use in people with stroke, cerebral palsy, or Parkinson's disease is not recommended. Intrathecal baclofen is used for severe spasticity of spinal cord origin, that is refractive to maximum doses of oral antispasmodic agents, or who experience intolerable side effects. Baclofen is also indicated as a treatment for alcohol use disorder in which it is effective in reducing the risk of relapse, and to increase the number of days that a person can go without drinking alcohol (abstinence days), though this indication remains off-label in many countries It is sometimes used off-label for the treatment of opioid withdrawal symptoms, and may be superior for this purpose to the more-commonly used clonidine. Baclofen is also used in the treatment of sleep-related painful erections. It increases slow-wave sleep.
Sources: en.wikipedia.org
==== Butyrophenone(s) ==== Lumateperone (Caplyta) – In December 2019, lumateperone, a presynaptic D2 receptor partial agonist and postsynaptic D2 receptor antagonist, received its first global approval in the US for the treatment of schizophrenia in adults. In 2020 and 2021 FDA approved for depressive episodes associated with bipolar I or II disorder in adults, as monotherapy and as adjunctive therapy with lithium or valproate.
ATP synthase, also called complex V, is the final enzyme in the oxidative phosphorylation pathway. This enzyme is found in all forms of life and functions in the same way in both prokaryotes and eukaryotes. The enzyme uses the energy stored in a proton gradient across a membrane to drive the synthesis of ATP from ADP and phosphate (Pi). Estimates of the number of protons required to synthesize one ATP have ranged from three to four, with some suggesting cells can vary this ratio, to suit different conditions.
Among measures it introduces is a licensing scheme for land where grouse shooting takes place, and regulations for traps. 22 March – A report prepared by Stirling University calls for artificial 3G football pitches to be banned in Scotland because they contain potentially cancer causing chemicals. Jasmin Paris from Midlothian becomes the first woman to complete the Barkley Marathons in the US state of Tennessee, doing so with one minute 39 seconds to spare of the 60-hour cut off. 27 March – Following a three-week hearing at Edinburgh Sheriff Court, former private school teacher John Brownlee, who worked at the Edinburgh Academy between 1967 and 1987, is found to have physically abused bos in his charge. He will not face trial though as he was earlier deemed to be medically unfit to do so. A group calling itself INC Ransom threatens to publish data stolen from NHS Dumfries and Galloway. VisitScotland announces that its 25 information centres will close over the next two years. 28 March – The Assisted Dying for Terminally Ill Adults (Scotland) Bill, a bill to legalise assisted dying in Scotland and drafted by Liberal Democrat MSP Liam McArthur, is introduced into the Scottish Parliament.
=== Self-assembly by molecular interactions === Nanoparticles have the ability to assemble chemically through covalent or noncovalent interactions with their capping ligand. The terminal functional group(s) on the particle are known as capping ligands. As these ligands tend to be complex and sophisticated, self-assembly can provide a simpler pathway for nanoparticle organization by synthesizing efficient functional groups. For instance, DNA oligomers have been a key ligand for nanoparticle building blocks to be self-assembling via sequence-based specific organization. However, to deliver precise and scalable (programmable) assembly for a desired structure, a careful positioning of ligand molecules onto the nanoparticle counterpart should be required at the building block (precursor) level, such as direction, geometry, morphology, affinity, etc. The successful design of ligand-building block units can play an essential role in manufacturing a wide-range of new nano systems, such as nanosensor systems, nanomachines/nanobots, nanocomputers, and many more uncharted systems.
14 April – Trixie Gardner, Baroness Gardner of Parkes, 96, British politician, member of the House of Lords since 1981 20 April – Doreen Massey, Baroness Massey of Darwen, 85, British politician, member of the House of Lords (since 1999). 23 April – Frank Field, Baron Field of Birkenhead, 81, British politician, MP (1979–2019) and member of the House of Lords (since 2020). David Marquand, 89, British politician and academic administrator, MP (1966–1977) and principal of Mansfield College, Oxford (1996–2002). 29 April – Andrew Stunell, Baron Stunell, 81, British politician, MP (1997–2015) and member of the House of Lords (since 2015). 10 May – Colin Breed, 76, British politician, MP (1997–2010). (death announced on this date) 12 May – Michael Brudenell-Bruce, 8th Marquess of Ailesbury, 98, British hereditary peer, army officer and stockbroker, member of the House of Lords (1974–1999). 24 May – Stuart Borrowman, 71, Scottish politician. 5 June – Charles Allsopp, 6th Baron Hindlip, 83, British peer and businessman, member of the House of Lords (1993–1999). 26 June – Richard Taylor, 89, British politician, MP (2001–2010). 29 July – Robert Fellowes, Baron Fellowes, 82, British courtier, private secretary to the sovereign (1990–1999) and member of the House of Lords (1999–2022). Peter Reddaway, 84, British-American political scientist. 4 August – Anthony Hamilton-Smith, 3rd Baron Colwyn, 82, British dentist and peer, member of the House of Lords (1967–2022). 22 August – Delwyn Williams, 85, British politician and solicitor, MP (1979–1983).
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.